The first-in-human trial for tebentafusp findings are in, and they show promise for managing a patients side effects to it.
Alexander N. Shoushtari, MD
Advertisement
Articles by Alexander N. Shoushtari, MD
Advertisement
Latest Updated Articles
First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety ProfilePublished: November 27th 2019 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Improving Access to Supportive Care on an Organizational Level, With Korie Bigbee
2
The “Owners” and “Managers” in the Peer-to-Peer Process: What an APP Should Know
3
Managing Acute and Late Adverse Effects of Breast Cancer Radiation
4
An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team
5
